Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Pliant Therapeutics (PLRX) Interest Expenses (2022 - 2025)

Pliant Therapeutics (PLRX) has disclosed Interest Expenses for 4 consecutive years, with $136000.0 as the latest value for Q4 2025.

  • Quarterly Interest Expenses fell 83.69% to $136000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.6 million through Dec 2025, down 15.38% year-over-year, with the annual reading at $2.6 million for FY2025, 15.38% down from the prior year.
  • Interest Expenses for Q4 2025 was $136000.0 at Pliant Therapeutics, down from $815000.0 in the prior quarter.
  • The five-year high for Interest Expenses was $877000.0 in Q3 2024, with the low at $136000.0 in Q4 2025.
  • Average Interest Expenses over 4 years is $509466.7, with a median of $321000.0 recorded in 2023.
  • The sharpest move saw Interest Expenses skyrocketed 176.66% in 2024, then tumbled 83.69% in 2025.
  • Over 4 years, Interest Expenses stood at $317000.0 in 2022, then increased by 1.26% to $321000.0 in 2023, then surged by 159.81% to $834000.0 in 2024, then crashed by 83.69% to $136000.0 in 2025.
  • According to Business Quant data, Interest Expenses over the past three periods came in at $136000.0, $815000.0, and $809000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.